Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Hildegard T Greinix"'
Publikováno v:
Turkish Journal of Hematology, Vol 25, Iss 04, Pp 164-171 (2008)
With the introduction of hematopoietic stem cell transplant (HSCT), transplant-associated problems like graft-versus-host disease (GVHD) and transplant-associated microangiopathy (TAM) have occurred. In addition, approximately 40% of allogeneic HSCTs
Externí odkaz:
https://doaj.org/article/de864964ac3c41fa8b12fbad3601cad4
Autor:
Stefan Hatzl, Florian Posch, Nazanin Sareban, Martin Stradner, Konrad Rosskopf, Alexander C. Reisinger, Philipp Eller, Michael Schörghuber, Wolfgang Toller, Zdenka Sloup, Florian Prüller, Katharina Gütl, Stefan Pilz, Alexander R. Rosenkranz, Hildegard T. Greinix, Robert Krause, Peter Schlenke, Gernot Schilcher
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background This study aimed to quantify the potential survival benefit of convalescent plasma therapy (CVP) in critically ill patients with acute respiratory failure related to coronavirus disease-2019 (COVID-19). Methods This is a single-ce
Externí odkaz:
https://doaj.org/article/a98ae351f6124254a83c929fde57044f
Autor:
Hildegard T. Greinix, Robert Knobler
Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer, namely cutaneous T-cell lymphoma, and has demonstrated efficacy in various diseases that have a suspected involvement of pathogenic T-cells including
Autor:
Eduard Schulz, Isabel Hodl, Patrick Forstner, Stefan Hatzl, Nazanin Sareban, Martina Moritz, Johannes Fessler, Barbara Dreo, Barbara Uhl, Claudia Url, Andrea J. Grisold, Michael Khalil, Barbara Kleinhappl, Christian Enzinger, Martin H. Stradner, Hildegard T. Greinix, Peter Schlenke, Ivo Steinmetz
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immunocompromised patients are considered high-risk and prioritized for vaccination against COVID-19. We aimed to analyze B-cell subsets in these patients to identify potential predictors of humoral vaccination response. Patients (n=120) suffering fr
Externí odkaz:
https://doaj.org/article/d95143a5e2e14deebe59299291a8d7cc
Autor:
Alois Gratwohl, Rafael Duarte, John A. Snowden, Anja van Biezen, Helen Baldomero, Jane Apperley, Jan Cornelissen, Hildegard T. Greinix, Eoin Mc Grath, Mohamad Mohty, Nicolaus Kroeger, Arnon Nagler, Dietger Niederwieser, Hein Putter, Ronald Brand
Publikováno v:
EClinicalMedicine, Vol 15, Iss , Pp 33-41 (2019)
Background: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. Methods: This Retros
Externí odkaz:
https://doaj.org/article/4b3ac3890f7f46f5a47f20c03e58cd04
Autor:
Rachel E. Crossland, Jean Norden, Sakhila Ghimire, Mateja Kralj Juric, Kim F. Pearce, Clare Lendrem, Matthew Collin, Eva Mischak-Weissinger, Ernst Holler, Hildegard T. Greinix, Anne M. Dickinson
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Introduction: Acute graft vs. host disease (aGvHD) is a frequent complication following allogeneic haematopoeitic transplantation (HSCT). Despite recent advances, there are no universally accepted biomarkers to determine development of aGvHD. MicroRN
Externí odkaz:
https://doaj.org/article/6b4aec1f30f54cbab126aacf0c1c3977
Autor:
Laurent Garderet, Luuk Gras, Linda Koster, Anita D'Souza, Noel Estrada-Merly, Parameswaran Hari, Wael Saber, Andrew J. Cowan, Minako Iida, Shinichiro Okamoto, Hiroyuki Takamatsu, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Nada Hamad, Bor-Sheng Ko, Christopher Liam, KIM Wah HO, A. Sim Goh, S. Keat Tan, Alaa M. Elhaddad, Ali Bazarbachi, Qamar un Nisa Chaudhry, Rozan Alfar, Mohamed-Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Hira S. Mian, Arleigh McCurdy, Feng Rong Wang, Daniel Neumann, Mickey Koh, John A. Snowden, Stefan Schönland, Donal P. McLornan, Patrick John Hayden, Anna Sureda, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger Niederwieser
Publikováno v:
Blood. 140:4839-4842
Publikováno v:
Leukemia. 36:2558-2566
Patients with steroid-refractory graft-versus-host disease (GvHD) are known to have a poor prognosis and for decades no approved drug has been available to treat this serious condition. Although ruxolitinib, a selective Janus kinase (JAK)1/2 inhibito
Autor:
Geoffrey D.E. Cuvelier, Michelle Schoettler, Nataliya P. Buxbaum, Iago Pinal-Fernandez, Marc Schmalzing, Jörg H.W. Distler, Olaf Penack, Bianca D. Santomasso, Robert Zeiser, Klemens Angstwurm, Kelli P.A. MacDonald, W. Taylor Kimberly, Naomi Taylor, Ervina Bilic, Bernhard Banas, Maike Buettner-Herold, Namita Sinha, Hildegard T. Greinix, Joseph Pidala, Kirk R. Schultz, Kirsten M. Williams, Yoshihiro Inamoto, Corey Cutler, Linda M. Griffith, Stephanie J. Lee, Stefanie Sarantopoulos, Steven Z. Pavletic, Daniel Wolff
Publikováno v:
Transplantation and Cellular Therapy. 28:426-445
Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and organ systems or manifest in atypical ways in classical organs commonly a
Autor:
Nina Worel, Mahmoud Aljurf, Chloe Anthias, Andreas S Buser, Meghann Cody, Mirjam Fechter, Sebastian Galeano, Hildegard T Greinix, Annika M Kisch, Mickey B C Koh, Thilo Mengling, Grazia Nicoloso, Dietger Niederwieser, Michael A Pulsipher, Adriana Seber, Bronwen E Shaw, Heather E Stefanski, Galen E Switzer, Jeff Szer, Suzanna M van Walraven, Hung Yang, Jörg P Halter
Publikováno v:
The Lancet Haematology. 9:e605-e614
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared with the strict r